A balance between innovation and biosafety
- PMID: 38976743
- PMCID: PMC11260158
- DOI: 10.1073/pnas.2410451121
A balance between innovation and biosafety
Conflict of interest statement
Competing interests statement:The author declares no competing interest.
Comment on
- doi: 10.1073/pnas.2310421121
Similar articles
-
Preparedness to face the COVID-19 pandemic - is India missing the mark?J Glob Health. 2020 Dec;10(2):020338. doi: 10.7189/jogh.10.020338. J Glob Health. 2020. PMID: 33214883 Free PMC article. Review. No abstract available.
-
India's Bhilwara COVID-19 containment policy response: Lessons for public health policy makers globally.J Glob Health. 2020 Dec;10(2):020325. doi: 10.7189/jogh.10.020325. J Glob Health. 2020. PMID: 33214882 Free PMC article. Review. No abstract available.
-
Dermatopathology practice in the era of COVID-19.Arch Dermatol Res. 2021 Dec;313(10):811-813. doi: 10.1007/s00403-020-02183-x. Epub 2021 Feb 9. Arch Dermatol Res. 2021. PMID: 33564894 Free PMC article. Review.
-
Biosafety Professionals: A Role in the Pandemic Response Team.Health Secur. 2021 Jul-Aug;19(4):454-458. doi: 10.1089/HS.2021.0015. Health Secur. 2021. PMID: 34415789 No abstract available.
-
A Cytometrist's Guide to Coordinating and Performing Effective COVID-19 Research.Cytometry A. 2021 Jan;99(1):11-18. doi: 10.1002/cyto.a.24210. Epub 2020 Sep 8. Cytometry A. 2021. PMID: 32881296 Free PMC article. Review.
Cited by
-
Reply to Masters: Recombinant coronavirus balances biosafety and benefit.Proc Natl Acad Sci U S A. 2024 Oct 29;121(44):e2416109121. doi: 10.1073/pnas.2416109121. Epub 2024 Oct 21. Proc Natl Acad Sci U S A. 2024. PMID: 39432797 Free PMC article. No abstract available.
References
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources